Is Trump Going to Kill Pharma and Valeant Stocks?
President-elect Donald Trump may not be the friend that the pharmaceutical industry had hoped for. Despite gaining in the early days following his election, the NASDAQ Biotechnology Index is down three percent on Wednesday as Trump vows to reduce drug prices. Among shares hit the hardest is Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock, down more than three percent.
The source of Wednesday's troubles for Valeant stock and other pharma industry shares is a Time magazine interview.
Den vollständigen Artikel lesen ...
President-elect Donald Trump may not be the friend that the pharmaceutical industry had hoped for. Despite gaining in the early days following his election, the NASDAQ Biotechnology Index is down three percent on Wednesday as Trump vows to reduce drug prices. Among shares hit the hardest is Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock, down more than three percent.
The source of Wednesday's troubles for Valeant stock and other pharma industry shares is a Time magazine interview.
Den vollständigen Artikel lesen ...